Lin‐Hung Wei

3.7k total citations
67 papers, 3.0k citations indexed

About

Lin‐Hung Wei is a scholar working on Molecular Biology, Oncology and Reproductive Medicine. According to data from OpenAlex, Lin‐Hung Wei has authored 67 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 23 papers in Oncology and 19 papers in Reproductive Medicine. Recurrent topics in Lin‐Hung Wei's work include Angiogenesis and VEGF in Cancer (16 papers), Ovarian cancer diagnosis and treatment (14 papers) and Endometrial and Cervical Cancer Treatments (11 papers). Lin‐Hung Wei is often cited by papers focused on Angiogenesis and VEGF in Cancer (16 papers), Ovarian cancer diagnosis and treatment (14 papers) and Endometrial and Cervical Cancer Treatments (11 papers). Lin‐Hung Wei collaborates with scholars based in Taiwan, China and United States. Lin‐Hung Wei's co-authors include Min‐Liang Kuo, Chi‐An Chen, Chia‐Hung Chou, Chang-Yao Hsieh, Jen-Liang Su, Yung‐Ming Jeng, Michael Hsiao, Chien‐Nan Lee, Chang‐Yao Hsieh and Ming‐Hsien Chien and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Cancer Cell.

In The Last Decade

Lin‐Hung Wei

62 papers receiving 2.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Lin‐Hung Wei 1.7k 1.1k 609 479 287 67 3.0k
Joseph Kwong 1.6k 1.0× 803 0.7× 757 1.2× 476 1.0× 313 1.1× 56 2.8k
Feliciano Baldi 1.5k 0.9× 1.0k 0.9× 361 0.6× 348 0.7× 287 1.0× 76 3.4k
Jermaine Coward 704 0.4× 1.2k 1.1× 354 0.6× 404 0.8× 318 1.1× 87 2.3k
Ulla Puistola 1.1k 0.7× 557 0.5× 731 1.2× 258 0.5× 689 2.4× 112 2.7k
Xiaoyan Xin 998 0.6× 426 0.4× 365 0.6× 338 0.7× 234 0.8× 115 1.9k
Anneke Geurts‐Moespot 804 0.5× 524 0.5× 531 0.9× 481 1.0× 124 0.4× 75 2.9k
Ramin Radpour 1.3k 0.8× 595 0.6× 704 1.2× 565 1.2× 120 0.4× 72 2.7k
Yoshito Terai 1.1k 0.7× 697 0.6× 451 0.7× 378 0.8× 908 3.2× 136 2.7k
Xingsheng Yang 800 0.5× 409 0.4× 412 0.7× 169 0.4× 334 1.2× 95 1.8k

Countries citing papers authored by Lin‐Hung Wei

Since Specialization
Citations

This map shows the geographic impact of Lin‐Hung Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin‐Hung Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin‐Hung Wei more than expected).

Fields of papers citing papers by Lin‐Hung Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin‐Hung Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin‐Hung Wei. The network helps show where Lin‐Hung Wei may publish in the future.

Co-authorship network of co-authors of Lin‐Hung Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Lin‐Hung Wei. A scholar is included among the top collaborators of Lin‐Hung Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin‐Hung Wei. Lin‐Hung Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chiang, Ying‐Cheng, et al.. (2025). Pembrolizumab combined with chemotherapy for advanced and recurrent endometrial cancer: A single-center retrospective study. Journal of the Formosan Medical Association. 2 indexed citations
3.
Guo, Shi‐Yao, Yu‐Tao Hu, Yong Rao, et al.. (2024). L‐aspartate ameliorates diet‐induced obesity by increasing adipocyte energy expenditure. Diabetes Obesity and Metabolism. 27(2). 606–618. 2 indexed citations
4.
Chen, Ji‐Qing, Tao Yu, Yu‐Cheng Liu, et al.. (2024). Loss of LECT2 promotes ovarian cancer progression by inducing cancer invasiveness and facilitating an immunosuppressive environment. Oncogene. 43(7). 511–523. 5 indexed citations
5.
Wei, Lin‐Hung, et al.. (2023). Effects of Dienogest on breasts of women of reproductive age and women in menopausal transition: A cohort study. International Journal of Gynecology & Obstetrics. 162(3). 1114–1116. 1 indexed citations
6.
Guo, Li, et al.. (2020). Ipriflavone attenuates the degeneration of cartilage by blocking the Indian hedgehog pathway. Osteoarthritis and Cartilage. 28. S477–S477. 1 indexed citations
7.
Chen, Min-Wei, Ming‐Hsien Chien, Kuo‐Tai Hua, et al.. (2017). The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer. Cancer Research. 77(8). 1955–1967. 128 indexed citations
8.
Hua, Kuo‐Tai, Wei-Jiunn Lee, Shun‐Fa Yang, et al.. (2013). Vascular endothelial growth factor-C modulates proliferation and chemoresistance in acute myeloid leukemic cells through an endothelin-1-dependent induction of cyclooxygenase-2. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(2). 387–397. 23 indexed citations
9.
Chien, Ming‐Hsien, et al.. (2012). Impacts of CA9 Gene Polymorphisms and Environmental Factors on Oral-Cancer Susceptibility and Clinicopathologic Characteristics in Taiwan. PLoS ONE. 7(12). e51051–e51051. 30 indexed citations
10.
Lin, Chung‐Wu, et al.. (2012). Role of lipocalin 2 and its complex with matrix metalloproteinase‐9 in oral cancer. Oral Diseases. 18(8). 734–740. 35 indexed citations
11.
Chien, Ming‐Hsien, Chao‐Bin Yeh, Lin‐Hung Wei, et al.. (2011). Relationship of interleukin‐8 gene polymorphisms with hepatocellular carcinoma susceptibility and pathological development. Journal of Surgical Oncology. 104(7). 798–803. 18 indexed citations
12.
Wei, Lin‐Hung, Pao‐Ling Torng, Sheng‐Mou Hsiao, et al.. (2011). Histone Deacetylase 6 Regulates Estrogen Receptor α in Uterine Leiomyoma. Reproductive Sciences. 18(8). 755–762. 24 indexed citations
13.
Chen, Min-Wei, Kuo‐Tai Hua, Lin‐Hung Wei, et al.. (2010). H3K9 Histone Methyltransferase G9a Promotes Lung Cancer Invasion and Metastasis by Silencing the Cell Adhesion Molecule Ep-CAM. Cancer Research. 70(20). 7830–7840. 297 indexed citations
14.
Lo, Chi‐Wen, Min‐Wei Chen, Michael Hsiao, et al.. (2010). IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer. Cancer Research. 71(2). 424–434. 152 indexed citations
15.
Su, Jen-Liang, Pan‐Chyr Yang, Jin‐Yuan Shih, et al.. (2007). The VEGF-C/Flt-4 Axis Promotes Invasion and Metastasis of Cancer Cells. Cancer Cell. 11(2). 207–207. 6 indexed citations
16.
Su, Jen-Liang, Jin‐Yuan Shih, Ming‐Shyen Yen, et al.. (2004). Cyclooxygenase-2 Induces EP1- and HER-2/Neu-Dependent Vascular Endothelial Growth Factor-C Up-Regulation. Cancer Research. 64(2). 554–564. 165 indexed citations
17.
Hsieh, Chang‐Yao, Chi‐An Chen, Chia‐Hung Chou, et al.. (2004). Overexpression of Her-2/neu in epithelial ovarian carcinoma induces vascular endothelial growth factor C by activating NF-κB: Implications for malignant ascites formation and tumor lymphangiogenesis. Journal of Biomedical Science. 11(2). 249–259. 30 indexed citations
18.
19.
Chen, Chi‐An, Wen‐Fang Cheng, Lin‐Hung Wei, Yi‐Ning Su, & Chang‐Yao Hsieh. (2002). Radical hysterectomy alone or combined with neoadjuvant chemotherapy in the treatment of early stage bulky cervical carcinoma.. PubMed. 101(3). 195–202. 13 indexed citations
20.
Chen, Chi‐An, Wen‐Fang Cheng, Chien‐Nan Lee, et al.. (2001). Cytosol Vascular Endothelial Growth Factor in Endometrial Carcinoma: Correlation with Disease-Free Survival. Gynecologic Oncology. 80(2). 207–212. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph Kwong Breakdown of academic impact, for papers by Feliciano Baldi Breakdown of academic impact, for papers by Jermaine Coward Breakdown of academic impact, for papers by Ulla Puistola Breakdown of academic impact, for papers by Xiaoyan Xin Breakdown of academic impact, for papers by Anneke Geurts‐Moespot Breakdown of academic impact, for papers by Ramin Radpour Breakdown of academic impact, for papers by Yoshito Terai Breakdown of academic impact, for papers by Xingsheng Yang
Rankless by CCL
2026